Cargando…

Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment

This study investigated how a history of menopausal hormone therapy (MHT) impacts clinical outcomes overall and in different subgroups of breast cancer patients. The study included 814 primary breast cancer patients aged ≥50 years in Sweden (2002–2012) with follow-up until 2016. Associations between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Godina, Christopher, Ottander, Erik, Tryggvadottir, Helga, Borgquist, Signe, Isaksson, Karolin, Jernström, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015974/ https://www.ncbi.nlm.nih.gov/pubmed/32117735 http://dx.doi.org/10.3389/fonc.2020.00080

Ejemplares similares

Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
por: Godina, Christopher, et al.
Publicado: (2023)

Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
por: Nilsson, Linn, et al.
Publicado: (2020)

Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: a prospective cohort study
por: Godina, Christopher, et al.
Publicado: (2021)

The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study
por: Tryggvadottir, Helga, et al.
Publicado: (2021)

Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
por: Sandén, Emma, et al.
Publicado: (2020)

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
por: Godina, Christopher, et al.
Publicado: (2022)

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
por: Khazaei, Somayeh, et al.
Publicado: (2022)

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients
por: Tryggvadottir, Helga, et al.
Publicado: (2018)

CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
por: Kimbung, Siker, et al.
Publicado: (2020)

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis
por: Wisse, Agatha, et al.
Publicado: (2018)

Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment
por: Björner, Sofie, et al.
Publicado: (2018)

Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
por: Gustbée, Emma, et al.
Publicado: (2015)

Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
por: Rosendahl, Ann H., et al.
Publicado: (2021)

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort
por: Elebro, Karin, et al.
Publicado: (2017)

Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
por: Inasu, Maria, et al.
Publicado: (2022)

FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics
por: Boraka, Öykü, et al.
Publicado: (2023)

Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer
por: Björner, Sofie, et al.
Publicado: (2017)

Adipocytes Under Obese-Like Conditions Change Cell Cycle Distribution and Phosphorylation Profiles of Breast Cancer Cells: The Adipokine Receptor CAP1 Matters
por: Bergqvist, Malin, et al.
Publicado: (2021)

Thyroid hormones and breast cancer association according to menopausal status and body mass index
por: Ortega-Olvera, Carolina, et al.
Publicado: (2018)

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
por: Marcus, David M., et al.
Publicado: (2013)

Low thyroid hormone receptor alpha-2 (THRα-2) tumor expression is associated with unfavorable tumor characteristics and high breast cancer mortality
por: Sandsveden, Malte, et al.
Publicado: (2021)

Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway
por: Botteri, Edoardo, et al.
Publicado: (2017)

Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)

Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer
por: Dodda, Balasunder R., et al.
Publicado: (2019)

Breastfeeding in relation to risk of different breast cancer characteristics
por: Butt, Salma, et al.
Publicado: (2014)

Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment
por: Ramalingam, Kirithiga, et al.
Publicado: (2023)

Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status
por: García-Estévez, Laura, et al.
Publicado: (2021)

Menopausal hormone therapy after breast cancer
por: Colditz, Graham A
Publicado: (2005)

Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer
por: Huss, Linnea, et al.
Publicado: (2014)

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study
por: Rosenberg, Lena U, et al.
Publicado: (2008)

Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study
por: Andersson, Gustav, et al.
Publicado: (2018)

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
por: Zhou, Danyang, et al.
Publicado: (2021)

Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer
por: Zheng, Caihong, et al.
Publicado: (2023)

Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients – An Analysis of GHSG HD14- and HD17-Patients
por: Rosenbrock, Johannes, et al.
Publicado: (2021)

Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
por: Borgquist, Signe, et al.
Publicado: (2008)

Evaluation of anti-Müllerian hormone in pre-menopausal women stratified according to thyroid function, autoimmunity and age
por: Giusti, Massimo, et al.
Publicado: (2022)

Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort
por: Dias, Joana A., et al.
Publicado: (2016)

Menopause Hormone Therapy in the Changing Trends of Breast Cancer in India
por: Meeta, Meeta, et al.
Publicado: (2020)

The Preferred Locations of Meningioma According to Different Biological Characteristics Based on Voxel-Wise Analysis
por: Sun, Chongran, et al.
Publicado: (2020)

Development of a Mouse Model of Menopausal Ovarian Cancer
por: Smith, Elizabeth R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ublusmeguhso488unrouhfelvu